BNP Paribas’s Korro Bio KRRO Stock Holding History

BNP Paribas’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-59	Closed	-$1.03K	–	360
2025 Q1	$1.03K	Buy	+59	New	+$1.75K	﹤0.01%	346

Other funds holding KRRO

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

QUSVM

Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

BNP Paribas's KRRO Position: Q2 2025 in Review

BNP Paribas sold out of Korro Bio (KRRO) in Q2 2025, closing a stake of 59 shares — an estimated $1.03K sold.

BNP Paribas first reported a position in KRRO in Q1 2025 and held it in 1 quarter. The position peaked at $1.03K in Q1 2025. 70 funds tracked by Wall St. Rank hold KRRO as of Q2 2025.

BNP Paribas reported no remaining Korro Bio position as of Q2 2025 after selling out during the quarter.
BNP Paribas sold 59 Korro Bio shares in Q2 2025, an estimated $1.03K.
BNP Paribas first reported a position in Korro Bio in Q1 2025 and held it in 1 quarter.
BNP Paribas's Korro Bio position peaked at $1.03K in Q1 2025.
70 funds tracked by Wall St. Rank held Korro Bio as of Q2 2025.

Based on BNP Paribas's 13F filing for Q2 2025, filed 14 Aug 2025.